Head-to-head · WeighScore
Gala Health vs GoodRx
By GLP-1 ScorecardUpdated
Score comparison
Gala Health has the higher recorded score — 82.9/100 to 69.6/100.
Gala Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Gala offers low advertised injection prices and a branded Ozempic path, but its campaign and longer-term plan pages need to be reconciled before paying.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Gala Health | GoodRx |
|---|---|---|
| WeighScore | 82.9/100 | 69.6/100 |
| Grade | B− | C |
| Site position | #12 | #132 |
| Semaglutide | From $129/mo (campaign; plan pages conflict—confirm billing term) | Wegovy pill from $149 at 1.5 mg; injection $199 for two qualifying fills then $349. Separate $39/mo care fee if subscribed; dose/offer conditions apply. |
| Tirzepatide | From $179/mo (campaign; yearly and three-month offers conflict—confirm term) | Zepbound KwikPen advertised from $299; dose-specific and 28-day supply/refill conditions apply. Separate $39/mo care fee if subscribed; confirm pharmacy quote. |
| Coverage | Coverage wording differs: all 50 on homepage, most U.S. states in campaign | Prescription savings at participating U.S. pharmacies; Care Direct weight-loss prescribing excludes Alabama and Louisiana. Confirm the specific treatment and pharmacy. |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Yes |
Site position #12 · B−
Strengths
- Campaign advertises $129 semaglutide and $179 tirzepatide with medication and telehealth visits included if prescribed
- Brand-name Ozempic path and broader menopause/HRT services listed
- Terms identify clinical practice networks; actual clinician and pharmacy assignment still need checking
What to consider
- Yearly, three-month and no-contract campaign presentations differ; do not assume an annual upfront charge or flat month-to-month terms
- Cancel at least 72 hours before renewal; ordinary cancellation does not produce a refund
- Medical-disqualification refund wording differs between full-refund and remaining/current-cycle provisions
- Dispensing pharmacy not identified for an individual order; oral option is a waitlist, not a current offer
Site position #132 · C
Strengths
- Free prescription discounts can be used without purchasing the weight-loss care subscription
- Current Care Direct menu names oral Wegovy, injectable Wegovy/HD, Foundayo tablets and Zepbound KwikPen
- Publishes a separate $39 monthly care fee rather than presenting it as the medication price
- Official terms name possible medical groups and dispensing pharmacies; the guide explains pharmacy selection
What to consider
- Medication is extra; dose offers do not establish continuing cost. Foundayo and Zepbound self-pay card savings end December 31, 2026
- The Zepbound page has an inconsistent 10 mg lowest-dose label; confirm device, strength and selected quote
- Support and terms differ on the initial care-charge trigger; renewals are automatic and cancellation requires at least one day’s notice
- Care Direct weight-loss treatment excludes Alabama and Louisiana, and the guide says no insurance prior-authorization submissions
- Actual dispensing branch, lab costs and refill timing still require confirmation; canceling does not guarantee a refund
Featured provider
Gala Health
Gala Health scores 82.9/100 (B−). Gala offers low advertised injection prices and a branded Ozempic path, but its campaign and longer-term plan pages need to be reconciled before paying.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.